HB 2365 — Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.

(2) "Drug paraphernalia" includes, but is not limited to:

(A) Kits used or intended for use in planting, propagating, cultivating, growing or harvesting any species of plant that is a controlled substance or from which a controlled substance can be derived;

(B) kits used or intended for use in manufacturing, compounding, converting, producing, processing or preparing controlled substances;

(C) isomerization devices used or intended for use in increasing the potency of any species of plant that is a controlled substance;

(D) testing equipment used or intended for use in identifying or in analyzing the strength, effectiveness or purity of controlled substances;

(E) scales and balances used or intended for use in weighing or measuring controlled substances;

(F) diluents and adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose and lactose that are used or intended for use in cutting controlled substances;

(G) separation gins and sifters used or intended for use in removing twigs and seeds from or otherwise cleaning or refining marijuana;

(H) blenders, bowls, containers, spoons and mixing devices used or intended for use in compounding controlled substances;

(I) capsules, balloons, envelopes, bags and other containers used or intended for use in packaging small quantities of controlled substances;

(J) containers and other objects used or intended for use in storing or concealing controlled substances;

(K) hypodermic syringes, needles and other objects used or intended for use in parenterally injecting controlled substances into the human body;

(L) objects used or primarily intended or designed for use in ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish, hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into the human body, such as:

(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with or without screens, permanent screens, hashish heads or punctured metal bowls;

(ii) water pipes, bongs or smoking pipes designed to draw smoke through water or another cooling device;

(iii) carburetion pipes, glass or other heat-resistant tubes or any other device used, intended to be used or designed to be used to cause vaporization of a controlled substance for inhalation;

(iv) smoking and carburetion masks;

(v) roach clips, objects used to hold burning material, such as a marijuana cigarette, that has become too small or too short to be held in the hand;

(vi) miniature cocaine spoons and cocaine vials;

(vii) chamber smoking pipes;

(viii) carburetor smoking pipes;

(ix) electric smoking pipes;

(x) air-driven smoking pipes;

(xi) chillums;

(xii) bongs;

(xiii) ice pipes or chillers;

(xiv) any smoking pipe manufactured to disguise its intended purpose;

(xv) wired cigarette papers;

or (xvi) cocaine freebase kits.

(3) "Drug paraphernalia" does not include:

(A) Any products, chemicals or materials described in K.S.A.

21- 5709(a), and amendments thereto;

or HOUSE BILL No.

2365—page 3 (B) any materials used or intended for use to test a substance for the presence of fentanyl, a fentanyl analog, ketamine or gamma hydroxybutyric acid.

(g) "Fentanyl-related controlled substance" means any substance designated in K.S.A.

65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b) (12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)(28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b) (54), (b)(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)(73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b) (80), (b)(81), (b)(82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103), (b)(104) (b)(66), (g)(1) or, (g)(2), (i) or 65-4107(c) (1), (c)(6), (c)(9), (c)(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog thereof.

(h) "Immediate precursor" means a substance that the state board of pharmacy has found to be and by rules and regulations designates as being the principal compound commonly used or produced primarily for use and that is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail or limit manufacture.

(i) "Isomer" means all enantiomers and diastereomers.

(j) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of or placing into pill or capsule form a controlled substance either directly or indirectly or by extraction from substances of natural origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis.

"Manufacture" does not include:

(1) The preparation or compounding of a controlled substance by an individual for the individual's own lawful use or the preparation, compounding, packaging or labeling of a controlled substance:

(A) By a practitioner or the practitioner's agent pursuant to a lawful order of a practitioner as an incident to the practitioner's administering or dispensing of a controlled substance in the course of the practitioner's professional practice;

or (B) by a practitioner or by the practitioner's authorized agent under such practitioner's supervision for the purpose of or as an incident to research, teaching or chemical analysis or by a pharmacist or medical care facility as an incident to dispensing of a controlled substance;

or (2) the addition of diluents or adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are intended for use in cutting a controlled substance.

(k) "Marijuana" means all parts of all varieties of the plant Cannabis whether growing or not, the seeds thereof, the resin extracted from any part of the plant and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin.

"Marijuana" does not include:

(1) The mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks, except the resin extracted therefrom, fiber, oil or cake or the sterilized seed of the plant that is incapable of germination;

(2) any substance listed in schedules II through V of the uniform controlled substances act;

(3) drug products approved by the United States food and drug administration as of the effective date of this act;

(4) cannabidiol (other trade name:

2-[(3-methyl-6-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol);

or (5) industrial hemp as defined in K.S.A.

2-3901, and amendments thereto, when cultivated, produced, possessed or used for activities authorized by the commercial industrial hemp act.

(l) "Minor" means a person under 18 years of age.

(m) "Narcotic drug" means any of the following whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination HOUSE BILL No.

2365—page 4 of extraction and chemical synthesis:

(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate;

(2) any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of the substances referred to in paragraph (1) but not including the isoquinoline alkaloids of opium;

(3) opium poppy and poppy straw;

(4) coca leaves and any salt, compound, derivative or preparation of coca leaves and any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves that do not contain cocaine or ecgonine.

(n) "Opiate" means any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction- sustaining liability.

"Opiate" does not include, unless specifically designated as controlled under K.S.A.

65-4102, and amendments thereto, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan).

"Opiate" does include its racemic and levorotatory forms.

(o) "Opium poppy" means the plant of the species Papaver somniferum l.

except its seeds.

(p) "Person" means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership, association or any other legal entity.

(q) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.

(r) "School property" means property upon which is located a structure used by a unified school district or an accredited nonpublic school for student instruction or attendance or extracurricular activities of pupils enrolled in kindergarten or any of the grades one through 12.

This definition shall not be construed as requiring that school be in session or that classes are actually being held at the time of the offense or that children must be present within the structure or on the property during the time of any alleged criminal act.

If the structure or property meets the above definition, the actual use of that structure or property at the time alleged shall not be a defense to the crime charged or the sentence imposed.

(s) "Simulated controlled substance" means any product that identifies itself by a common name or slang term associated with a controlled substance and that indicates on its label or accompanying promotional material that the product simulates the effect of a controlled substance.

21-54132025 isSupp. hereby amended to read as follows:

21-65-4105 5413.is hereby amended to read as follows:

(a)65-4105. Battery is:

(1) Knowingly(a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or recklesslysubstance causingis bodilythe harmDEA tocontrolled anothersubstances person;code that has been assigned to it.

or(b) Any (2) knowinglyof causingthe physicalfollowing contactopiates, withincluding anothertheir personisomers, whenesters, doneethers, insalts, aand rude,salts insultingof orisomers, angryesters manner.and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

(b) Aggravated(1) batteryAcetyl is:fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide).............9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide)............................................9815 (3) Acetylmethadol.......................................................................9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacrylamide;

(1)acryloylfentanyl)...............................................................................9811 (A) Knowingly(5)(2) causingAH-7921 great(3,4-dichloro-N-[(1- bodilydimethylamino)cyclohexylmethyl]benzamide).......................9551 harm(6)(3) toAllylprodine............................................................................9602 anotherHOUSE personBILL orNo. disfigurement of another person;

(B) knowingly2365—page causing5 bodily(7)(4) harmAlphacetylmethadol................................................................9603 to(except anotherlevo-alphacetylmethadol personalso withknown aas deadlylevo-alpha- weapon,acetylmethadol, levomethadyl acetate or inLAAM) any(8)(5) mannerAlphameprodine......................................................................9604 whereby(9)(6) greatAlphamethadol........................................................................9605 bodily(10) harm,Alpha′-methyl disfigurementbutyryl orfentanyl death(2-methyl-N-(1- canphenethylpiperidin-4-yl)-N-phenylbutanamide).....................9864 be(11) inflicted;Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4- piperidyl] propionanilide;

or1-(1-methyl-2-phenylethyl)-4-(N- (C) knowinglypropanilido) causingpiperidine)..........................................................9814 physical(12) contactAlpha-methylthiofentanyl with(N-[1-methyl-2-(2-thienyl)ethyl-4- anotherpiperidinyl]-N-phenylpropanamide).......................................9832 person(13)(7) whenBenzethidine.........................................................................9606 done(14)(8) inBetacetylmethadol................................................................9607 a(15) rude,Beta-hydroxyfentanyl insulting(N-[1-(2-hydroxy-2-phenethyl)-4- orpiperidinyl]-N-phenylpropanamide).......................................9830 angry(16) mannerBeta-hydroxy-3-methylfentanyl with(other aname: deadly weapon, or in any manner whereby great bodily harm, disfigurement or death can be inflicted;

(2)N-[1-(2-hydroxy-2- (A) recklesslyphenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide)..9831 causing(17) greatBeta-hydroxythiofentanyl bodily(N-[1-[2-hydroxy-2-(thiophen-2- harmyl)ethyl]piperidin-4-yl]-N-phenylpropionamide)...................9836 to(18)(9) anotherBetameprodine......................................................................9608 person(19)(10) orBetamethadol......................................................................9609 disfigurement(20) ofBeta-methyl anotherfentanyl person;(N-phenyl-N-(1-(2-phenylpropyl)piperidin- 4-yl)propionamide;

(B) recklesslyalso causingknown bodilyas harmβ-methyl tofentanyl)...........9856 another(21) personBeta'-phenyl withfentanyl a(N-(1-phenethylpiperidin-4-yl)-N, deadly3- weapon,diphenylpropanamide; or in any manner whereby great bodily harm, disfigurement or death can be inflicted;

oralso (3)known (A) committingas anβ'-phenyl actfentanyl; described in K.S.A.

8-1567,3- andphenylpropanoyl amendmentsfentanyl)......................................................9842 thereto,(22)(11) whenBetaprodine.........................................................................9611 great(23)(12) bodilyBrorphine harm(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3- todihydro-2H-benzo[d]imidazol-2-one).....................................9098 another(24)(13) personButonitazene or(2-(2-(4-butoxybenzyl)-5-nitro-1 disfigurementH of-benzimidazol-1-yl)- anotherN,N person-diethylethan-1-amine)..................9751 resultsButyryl fromfentanyl such(N-(1-phenethylpiperidin-4-yl)-N- act;phenylbutyramide)..................................................................9822 (25)(14) Clonitazene.........................................................................9612 (26) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N- phenylbut-2-enamide).............................................................9844 (27) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopentanecarboxamide)...........................................9847 (28) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide)..........................................9845 (29)(15) Dextromoramide.................................................................9613 (30)(16) Diampromide......................................................................9615 (31)(17) Diethylthiambutene.............................................................9616 (32)(18) Difenoxin............................................................................9168 (33)(19) Dimenoxadol.......................................................................9617 (34)(20) Dimepheptanol....................................................................9618 (35) 2′,5′-Dimethoxyfentanyl (N-(1-(2,5- dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) .................................................................................................9861 (36)(21) Dimethylthiambutene..........................................................9619 (37)(22) Dioxaphetyl butyrate...........................................................9621 (38)(23) Dipipanone..........................................................................9622 (39)(24) 2-(2-(4-ethoxybenzyl)-1 H -benzimidazol-1-yl)- N,N -diethylethan-1-amine (Other names:

oretodesnitazene; (B) committing an act described in K.S.A.

8-1567,etazene) and................................................................................................9765 amendments(25) thereto,2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 whenH bodily-benzimidazole harm(Other tonames: another person results from such act under circumstances whereby great bodily harm, disfigurement or death can HB 2365—Am.

byN SC-piperidinyl 3etonitazene; result from such act;

oretonitazepipne)........................................................................9761 (4) committing(26) an2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 actH described-benzimidazole in(Other K.S.A.names:

8-1567,N and-pyrrolidino amendmentsetonitazene; thereto, when great bodily harm to another person or disfigurement of another person results from such act while:

(A) Inetonitazepyne).........................................................................9758 violation(27) ofEthylmethylthiambutene.........................................................9623 any(40)(28) restrictionEtonitazene..........................................................................9624 imposedHOUSE onBILL suchNo. person's driving privileges pursuant to article 10 of chapter 8 of the Kansas Statutes Annotated, and amendments thereto;

(B) such2365—page person's6 driving(41)(29) privilegesEtoxeridine..........................................................................9625 are(42) suspendedFentanyl orcarbamate revoked(ethyl pursuant(1-phenethylpiperidin-4-yl) to(phenyl)carbamate).................................................................9851 article(43) 102′-Fluoro ofortho-fluorofentanyl chapter(N-(1-(2- 8fluorophenethyl)piperidin-4-yl)-N-(2- offluorophenyl)propionamide; the Kansas Statutes Annotated, and amendments thereto;

oralso (C) suchknown personas has2′-fluoro been2- deemedfluorofentanyl)........................................................................9855 a(44)(30) habitualFlunitazene violator( asN,N defined-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1 inH K.S.A.-benzimidazol-1-yl)ethan-1-amine)........................................9756 Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran- 2-carboxamide).......................................................................9834 (45) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylfuran-3- carboxamide).....................................................................................9860 (46)(31) Furethidine..........................................................................9626 (47)(32) 7-hydroxymitragynine (7-OH) (33) Hydroxypethidine....................................................................9627 (48) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylisobutyramide)..............................................................9827 (49)(34) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro- 1H-benzimidazol-1-yl)ethan-1-amine;

8-285,N,N-diethyl-2-[[4-(1- andmethylethoxy)phenyl]methyl]-5-nitro-1 amendmentsH-benzimidazole-1- thereto,ethanamine).............................................................................9614 including(50) atIsovaleryl leastfentanyl one(3-methyl- violationN of-(1-phenethylpiperidin-4-yl)- K.S.A.N-phenylbutanamide)..............................................................9862 (51)(35) Ketobemidone.....................................................................9628 (52)(36) Levomoramide....................................................................9629 (53)(37) Levophenacylmorphan........................................................9631 (54) Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1- phenethylpiperidin-4-yl)propionamide)..................................9857 (55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -(1- phenethylpiperidin-4-yl)isobutyramide).................................9858 (56) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4- yl)-N-phenylacetamide)..........................................................9825 (57)(38) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H -benzimidazole (Other names:

8-1567,N and-pyrrolidino amendmentsmetonitazene; thereto, or violating an ordinance of any city in this state, any resolution of any county in this state or any law of another state, which ordinance, resolution or law declares to be unlawful the acts prohibited by that statute.

(c) Batterymetonitazepyne)......................................................................9762 against(39) a2-Methyl lawAP-237 enforcement(1-(2-methyl-4-(3-phenylprop-2-en-1- officeryl)piperazin-1-yl) is:butan-1-one) ..........................................................................9664 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N- phenylacetamide)....................................................................9819 (58) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N- phenylpropanamide)..........................................................................9813 (59) 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide).......................................9833 (60)(40) Metodesnitazene ( N,N -diethyl-2-(2-(4-methoxybenzyl)-1 H -benzimidazol-1-yl)ethan-1-amine) .......................................9764 (41) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H- benzimidazol-1-yl)ethan-1-amine)..........................................9757 (61)(42) Morpheridine......................................................................9632 (62)(43) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine).........9661 (63)(44) MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)piperazine)....9560 (64)(45) N- ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H -benzimidazol- 1-yl)ethan-1-amine (Other name:

(1) BatteryN as-desethyl definedisotonitazene)9760 in(46) subsectionN,N (a)(2)-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1 committedH against-benzimidazol- a:1-yl)ethan-1-amine (Other name:

(A) Uniformedprotonitazene)...................9759 or(47) properly5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 identifiedH university-benzimidazole or(Other campusnames: police officer while such officer is engaged in the performance of such officer's duty;

(B) uniformedN or-pyrrolidino properlyprotonitazene; identified state, county or city law enforcement officer, other than a state correctional officer or employee, a city or county correctional officer or employee or a juvenile detention facility officer, or employee, while such officer is engaged in the performance of such officer's duty;

(C) uniformedprotonitazepyne).....................................................................9763 or(48) properlyNoracymethadol......................................................................9633 identified(65)(49) federalNorlevorphanol...................................................................9634 law(66)(50) enforcementNormethadone.....................................................................9635 officerHOUSE whileBILL suchNo. officer is engaged in the performance of such officer's duty;

(D) judge,2365—page while7 such(67)(51) judgeNorpipanone........................................................................9636 is(68) engagedOcfentanil in(N-(2-fluorophenyl)-2-methoxy-N-(1- thephenethylpiperidin-4-yl) performanceacetamide).........................................................................................9838 of(69)(52) suchO-desmethyltramadol judge's(Some duty;trade or other names:

(E) attorney,2- while((dimethylamino)methyl-1-(3-hydroxyphenyl)cyclohexanol;3-(2- such((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol) attorney(70) isOrtho-fluoroacryl engagedfentanyl in(N-(2-fluorophenyl)-N-(1- thephenethylpiperidin-4-yl)acrylamide)......................................9852 performance(71) ofOrtho-fluorobutyryl suchfentanyl attorney's(N-(2-fluorophenyl)-N-(1- duty;phenethylpiperidin-4-yl)butyramide;

oralso (F) communityknown correctionsas officer2- orfluorobutyryl courtfentanyl)............................................................9846 services(72) officer,Ortho-fluorofentanyl while(N-(2-fluorophenyl)-N-(1- suchphenethylpiperidin-4-yl)propionamide; officer is engaged in the performance of such officer's duty;

(2) battery2-fluorofentanyl)......9816 as(73) definedOrtho in-Fluorofuranyl subsectionfentanyl (a)(1)( committedN against-(2-fluorophenyl)- a:N -(1- phenethylpiperidin-4-yl)furan-2-carboxamide)......................9863 (74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1- phenethylpiperidin-4-yl)isobutyramide).................................9853 (75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1- phenethylpiperidin-4-yl)acetamide;

(A) Uniformedalso orknown properlyas identified2-methyl universityacetylfentanyl).........................................................................9848 or(76) campusOrtho-methyl policemethoxyacetyl officerfentanyl while(2-methoxy-N-(2- suchmethylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; officer is engaged in the performance of such officer's duty;

(B) uniformedalso orknown properlyas identified2-methyl state,methoxyacetyl countyfentanyl)..................................................................................9820 or(77) cityPara-chloroisobutyryl lawfentanyl enforcement(N-(4-chlorophenyl)-N-(1- officer,phenethylpiperidin-4-yl)isobutyramide).................................9826 other(78) thanPara-fluorobutyryl afentanyl state(N-(4-fluorophenyl)-N-(1- correctionalphenethylpiperidin-4-yl)butyramide)......................................9823 officer(79) orPara-fluorofentanyl employee,(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- apiperidinyl]propanamide)........................................................9812 city(80) orPara-fluoroisobutyryl countyfentanyl correctional(N-(4-fluorophenyl)-N-(1- officerphenethylpiperidin-4-yl)isobutyramide, or4-fluoroisobutyryl employeefentanyl)..................................................................................9824 or(81) aPara-fluoro juvenilefuranyl detentionfentanyl facility(N-(4-fluorophenyl)-N-(1- officer,phenethylpiperidin-4-yl)furan-2-carboxamide)......................9854 or(82) employee,Para-methoxybutyryl whilefentanyl such(N-(4-methoxyphenyl)-N-(1- officerphenethylpiperidin-4-yl)butyramide)......................................9837 is(83) engagedPara in-Methoxyfuranyl thefentanyl performance( ofN such-(4-methoxyphenyl)- officer'sN duty;-(1- phenethylpiperidin-4-yl)furan-2-carboxamide........................9859 (84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N -(1- phenethylpiperidin-4-yl)cyclopropanecarboxamide)..............9865 (85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1- phenethylpiperidin-4-yl)propionamide;

HBalso 2365—Am.known as 4- methylfentanyl).......................................................................9817 (86)(53) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine)..9663 (87)(54) Phenadoxone.......................................................................9637 (88)(55) Phenampromide..................................................................9638 (89)(56) Phenomorphan....................................................................9647 (90)(57) Phenoperidine.....................................................................9641 (91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylbenzamide;

byalso SCknown 4as (C) uniformedbenzoyl orfentanyl)...............9841 properly(92)(58) identifiedPiritramide..........................................................................9642 federal(93)(59) lawProheptazine........................................................................9643 enforcement(94)(60) officerProperidine..........................................................................9644 while(95)(61) suchPropiram..............................................................................9649 officer(96)(62) isRacemoramide....................................................................9645 engaged(97) inTetrahydrofuranyl thefentanyl performance(N-(1-phenethylpiperidin-4-yl)-N- ofphenyltetrahydrofuran-2-carboxamide)..................................9843 such(98) officer'sThiofentanyl duty;(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide)..........................................................................9835 (99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylthiophene-2-carboxamide;

(D) judge,also whileknown suchas judge2-thiofuranyl isfentanyl; engaged in the performance of such judge's duty;

(E) attorney,thiophene whilefentanyl)..................................................9839 suchHOUSE attorneyBILL isNo. engaged in the performance of such attorney's duty;

or2365—page (F) community8 corrections(100)(63) officerTilidine..............................................................................9750 or(101)(64) courtTrimeperidine....................................................................9646 services(102)(65) officer,U-47700 while(3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N- suchmethylbenzamide).............................................................................9547 officer(103) isValeryl engagedfentanyl in(N-(1-phenethylpiperidin-4-yl)-N- phenylpentanamide)................................................................9840 (104)(66) Zipeprol (1-methoxy-3-[4-(2-methoxy-2- phenylethyl)piperazin-1-yl]-1- phenylpropan-2-ol)..................................................................9873 (c) Any of the performancefollowing opium derivatives, their salts, isomers and salts of suchisomers, officer'sunless duty;specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Acetorphine.............................................................................9319 (2) Acetyldihydrocodeine.............................................................9051 (3) Benzylmorphine......................................................................9052 (4) Codeine methylbromide..........................................................9070 (5) Codeine-N-Oxide....................................................................9053 (6) Cyprenorphine.........................................................................9054 (7) Desomorphine.........................................................................9055 (8) Dihydromorphine....................................................................9145 (9) Drotebanol...............................................................................9335 (10) Etorphine (except hydrochloride salt).....................................9056 (11) Heroin......................................................................................9200 (12) Hydromorphinol......................................................................9301 (13) Methyldesorphine....................................................................9302 (14) Methyldihydromorphine.........................................................9304 (15) Morphine methylbromide.......................................................9305 (16) Morphine methylsulfonate......................................................9306 (17) Morphine-N-Oxide..................................................................9307 (18) Myrophine...............................................................................9308 (19) Nicocodeine............................................................................9309 (20) Nicomorphine.........................................................................9312 (21) Normorphine...........................................................................9313 (22) Pholcodine...............................................................................9314 (23) Thebacon.................................................................................9315 (d) Any material, compound, mixture or (3) batterypreparation asthat definedcontains inany subsectionquantity (a)of committedthe againstfollowing a:hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(A) State(1) correctionalAlpha-ethyltryptamine officer...........................................................7249 orSome employeetrade by a person in custody of the secretary of corrections, while such officer or employeeother isnames: engaged in the performance of such officer's or employee's duty;

(B) stateetryptamine; correctional officer or employee by a person confined in such juvenile correctional facility, while such officer or employee is engaged in the performance of such officer's or employee's duty;

(C) juvenileMonase; detention facility officer or employee by a person confined in such juvenile detention facility, while such officer or employee is engaged in the performance of such officer's or employee's duty;

orα-ethyl-1H- (D) cityindole-3-ethanamine; or county correctional officer or employee by a person confined in a city holding facility or county jail facility, while such officer or employee is engaged in the performance of such officer's or employee's duty.

(d) Aggravated3-(2-aminobutyl) batteryindole; against a law enforcement officer is:

(1) Aggravatedα-ET; battery as defined in subsection (b)(1)(A) committed against a:

(A) Uniformedand orAET. properly identified state, county or city law enforcement officer while the officer is engaged in the performance of the officer's duty;

(B) uniformed(2) or4-bromo-2,5-dimethoxy-amphetamine...................................7391 properlySome identifiedtrade university or campusother policenames: officer while such officer is engaged in the performance of such officer's duty;

(C) uniformed4-bromo-2,5-dimethoxy-alpha- ormethylphenethylamine; properly identified federal law enforcement officer while such officer is engaged in the performance of such officer's duty;

(D) judge,4-bromo-2,5-DMA. while such judge is engaged in the performance of such judge's duty;

(E) attorney,(3) while2,5-dimethoxyamphetamine....................................................7396 suchSome attorneytrade isor engagedother innames: the performance of such attorney's duty;

or2,5-dimethoxy-alpha-methyl- (F) communityphenethylamine; corrections officer or court services officer, while such officer is engaged in the performance of such officer's duty;

(2) aggravated2,5-DMA. battery as defined in subsection (b)(1)(B) or (b)(1)(C) committed against a:

(A) Uniformed(4) or4-methoxyamphetamine..........................................................7411 properlySome identifiedtrade state, county or cityother lawnames: enforcement officer while the officer is engaged in the performance of the HB 2365—Am.

by4-methoxy-alpha-methylphene- SCthylamine; 5 officer's duty;

(B) uniformedparamethoxyamphetamine; or properly identified university or campus police officer while such officer is engaged in the performance of such officer's duty;

(C) uniformedPMA. or properly identified federal law enforcement officer while such officer is engaged in the performance of such officer's duty;

(D) judge,(5) while5-methoxy-3,4-methylenedioxy-amphetamine.......................7401 such(6) judge4-methyl-2,5-dimethoxy-amphetamine...................................7395 isSome engagedtrade inor theother performancenames: of such judge's duty;

(E) attorney,4-methyl-2,5-dimethoxy-alpha- whilemethylphenethylamine; such attorney is engaged in the performance of such attorney's duty;

or"DOM"; (F) community corrections officer or court services officer, while such officer is engaged in the performance of such officer's duty;

orand (3) knowingly"STP". causing, with a motor vehicle, bodily harm to a:

(A) Uniformed(7) or3,4-methylenedioxy properlyamphetamine..........................................7400 identified(8) state,3,4-methylenedioxymethamphetamine county(MDMA)...................7405 or(9) city3,4-methylenedioxy-N-ethylamphetamine law(also enforcementknown officeras whileN- theethyl-alpha-methyl-3,4 officer(methylenedioxy) isphenethylamine, engagedN- inethyl theMDA, performanceMDE, ofand theMDEA)..............................................7404 officer's(10) duty;N-hydroxy-3,4-methylenedioxyamphetamine (also known as N- hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine, HOUSE BILL No.

(B) uniformed2365—page or9 properlyand identifiedN-hydroxy universityMDA).............................................................7402 or(11) campus3,4,5-trimethoxy policeamphetamine...............................................7390 officer(12) whileBufotenine...............................................................................7433 suchSome officertrade isor engagedother innames: the performance of such officer's duty;

or3-(Beta-Dimethylaminoethyl)-5- (C) uniformedhydroxyindole; or properly identified federal law enforcement officer while such officer is engaged in the performance of such officer's duty.

(e) Battery3-(2-dimethylaminoethyl)-5-indolol; against a school employee is a battery as defined in subsection (a) committed against a school employee in or on any school property or grounds upon which is located a building or structure used by a unified school district or an accredited nonpublic school for student instruction or attendance or extracurricular activities of pupils enrolled in kindergarten or any of the grades one through 12 or at any regularly scheduled school sponsored activity or event, while such employee is engaged in the performance of such employee's duty.

(f) BatteryN, againstN- adimethylserotonin; mental health employee is a battery as defined in subsection (a) committed against a mental health employee by a person in the custody of the secretary for aging and disability services, while such employee is engaged in the performance of such employee's duty.

(g) Battery5-hydroxy-N,N-dimethyltryptamine; against a healthcare provider is a battery as defined in subsection (a) committed against a healthcare provider while such provider is engaged in the performance of such provider's duty.

(h)mappine. (1) Battery is a class B person misdemeanor.

(2) Aggravated(13) batteryDiethyltryptamine...................................................................7434 asSome definedtrade in:or other names:

(A) SubsectionN,N-Diethyltryptamine; (b)(1)(A) or (b)(4) is a severity level 4, person felony;

(B) subsectionDET. (b)(1)(B) or (b)(1)(C) is a severity level 7, person felony;

(C) subsection(14) (b)(2)(A)Dimethyltryptamine................................................................7435 orSome (b)(3)(A)trade isor aother severitynames: level 5, person felony;

andDMT. HB 2365—Am.

by(15) SCIbogaine...................................................................................7260 6Some (D) subsectiontrade (b)(2)(B) or (b)(3)(B)other isnames: a severity level 8, person felony.

(3) Battery7-Ethyl-6,6 againstBeta,7,8,9,10,12,13- aoctahydro-2-methoxy-6,9-methano-5H- lawpyrido[1',2':1,2]azepino[5,4-b]indole; enforcement officer as defined in:

(A) SubsectionTabernanthe (c)(1)iboga is(16) aLysergic classacid Apersondiethylamide.....................................................7315 misdemeanor;(17) Marijuana................................................................................7360 (18) Mescaline................................................................................7381 (19) Parahexyl.................................................................................7374 Some trade or other names:

(B) subsection3-Hexyl-l-hydroxy-7,8,9,10- (c)(2)tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; is a severity level 7, person felony;

andSynhexyl. (C) subsection (c)(3) is a severity level 5, person felony.

(4) Aggravated(20) batteryPeyote......................................................................................7415 againstMeaning aall lawparts enforcementof officerthe plant presently classified botanically as definedLophophora in:williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture or preparation of such plant, its seeds or extracts.

(A) Subsection(21) (d)(1)N-ethyl-3-piperidyl orbenzilate..................................................7482 (d)(3)(22) isN-methyl-3-piperidyl abenzilate...............................................7484 severity(23) levelPsilocybin................................................................................7437 3,(24) personPsilocyn...................................................................................7438 felony;Some trade or other names:

andPsilocin. (B) subsection (d)(2) is a severity level 4, person felony.

(5) Battery(25) againstEthylamine aanalog schoolof employeephencyclidine.......................................7455 isSome atrade classor Aother personnames: misdemeanor.

(6) BatteryN-ethyl-1-phenyl-cyclo-hexylamine; against a mental health employee is a severity level 7, person felony.

(7) Battery(1-phenylcyclohexyl)ethylamine; against a healthcare provider is a class A person misdemeanor.

(i) AsN-(1- usedphenylcyclohexyl)ethylamine; in this section:

(1) "Correctionalcyclohexamine; institution" means any institution or facility under the supervision and control of the secretary of corrections;

(2) "statePCE. correctional officer or employee" means any officer or employee of the Kansas department of corrections or any independent contractor, or any employee of such contractor, whose duties include working at a correctional institution;

(3) "juvenile(26) detentionPyrrolidine facilityanalog officerof orphencyclidine.......................................7458 employee"Some meanstrade any officer or employeeother ofnames: a juvenile detention facility as defined in K.S.A.

38-2302,1-(1-phenylcyclohexyl)-pyrrolidine; and amendments thereto;

(4) "cityPCPy; or county correctional officer or employee" means any correctional officer or employee of the city or county or any independent contractor, or any employee of such contractor, whose duties include working at a city holding facility or county jail facility;

(5) "schoolPHP. employee" means any employee of a unified school district or an accredited nonpublic school for student instruction or attendance or extracurricular activities of pupils enrolled in kindergarten or any of the grades one through 12;

(6) "mental(27) healthThiophene employee"analog means:of phencyclidine........................................7470 Some trade or other names:

(A) An1-[1-(2-thienyl)-cyclohexyl]- employeepiperidine; of the Kansas department for aging and disability services working at Larned state hospital, Osawatomie state hospital, south central regional mental health hospital, Kansas neurological institute and Parsons state hospital and training center and the treatment staff as defined in K.S.A.

59-29a02,2-thienyl andanalog amendmentsof thereto;phencyclidine;

andTPCP; (B) contractors and employees of contractors under contract to provide services to the Kansas department for aging and disability services HB 2365—Am.

byTCP. SC 7 working at any such institution or facility;

(7) "judge"(28) means1-[1-(2-thienyl)-cyclohexyl] apyrrolidine.................................7473 dulySome electedother ornames: appointed justice of the supreme court, judge of the court of appeals, judge of any district court of Kansas, district magistrate judge or municipal court judge;

(8) "attorney"TCPy. means a:

(A)(29) County2,5-dimethoxy-4-ethylamphetamine.......................................7399 attorney,Some assistanttrade county attorney, special assistant county attorney, district attorney, assistant district attorney, special assistant district attorney, attorney general, assistant attorney general or specialother assistantnames: attorney general;

andDOET. (B) public defender, assistant public defender, contract counsel for the state board of indigents' defense services or an attorney who is appointed by the court to perform services for an indigent person as provided by article 45 of chapter 22 of the Kansas StatutesAnnotated, and amendments thereto;

(9) "community(30) correctionsSalvia officer"divinorum means an employee of a community correctional services program responsible for supervision of adults or juvenilessalvinorum asA; assigned by the court to community corrections supervision and any other employee of a community correctional services program that provides enhanced supervision of offenders such as house arrest and surveillance programs;

(10) "courtall servicesparts officer"of meansthe anplant employeepresently ofclassified thebotanically Kansasas judicialsalvia branchdivinorum, orwhether localgrowing judicialor districtnot, responsiblethe forseeds supervising,thereof, monitoringany orextract writingfrom reportsany relatingpart toof adultssuch orplant, juvenilesand asevery assignedcompound, bymanufacture, thesalts, court,derivative, mixture or performingpreparation relatedof dutiessuch asplant, assignedits byseeds theor court;extracts.

(11) "federal(31) lawDatura enforcementstramonium, officer"commonly meansknown a law enforcement officer employed by the United States federal government who, as partgypsum ofweed suchor officer'sjimson duties,weed; is permitted to make arrests and to be armed;

andall (12) "healthcareparts provider"of meansthe anplant individualpresently whoclassified isbotanically licensed,as registered,datura certifiedstramonium, orwhether otherwisegrowing authorizedor bynot, the stateseeds thereof, any extract from any part of Kansassuch toplant, provideand healthcareevery servicescompound, inmanufacture, thissalts, state.derivative, mixture or preparation of such plant, its seeds or extracts.

(32) 1-(3-[trifluoromethylphenyl])piperazine Some trade or other names:

TFMPP.

(33) 4-Bromo-2,5-dimethoxyphenethylamine................................7392 (34) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its optical isomers, salts and salts of optical isomers...................7348 (35) Alpha-methyltryptamine (other name:

AMT).........................7432 (36) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its HOUSE BILL No.

2365—page 10 isomers, salts and salts of isomers..........................................7439 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E)............7509 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).........7508 (39) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C)..........7519 (40) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I)...............7518 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2).7385 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-4)...............................................................7532 (43) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)........................7517 (44) 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N)............7521 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P)....7524 (46) 5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT)..........7431 Some trade or other names:

5–methoxy–3–[2–(dimethylamino) ethyl]indole.

(47) 2–(4–iodo–2,5–dimethoxyphenyl)–N–(2– methoxybenzyl)ethanamine....................................................7538 Some trade or other names:

25I–NBOMe;

2C–I–NBOMe;

25I;

Cimbi–5.

(48) 2–(4–chloro–2,5–dimethoxyphenyl)–N–(2– methoxybenzyl)ethanamine....................................................7537 Some trade or other names:

25C–NBOMe;

2C–C–NBOMe;

25C;

Cimbi–82.

(49) 2–(4–bromo–2,5–dimethoxyphenyl)–N–(2– methoxybenzyl)ethanamine....................................................7536 Some trade or other names:

25B–NBOMe;

2C–B–NBOMe;

25B;

Cimbi–36.

(50) 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine Some trade or other names:

25H-NBOMe.

(51) 2-(2,5-dimethoxy-4-methylphenyl)-N-(2- methoxybenzyl)ethanamine Some trade or other names:

25D-NBOMe;

2C-D-NBOMe.

(52) 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2- methoxybenzyl)ethanamine Some trade or other names:

25N-NBOMe, 2C-N-NBOMe.

(53) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3- b]pyridine-3-carboxamide (5F-CUMYL-P7AICA)................7085 (54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other names:

methoxetamine, MXE)...............................................7286 (55) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names:

para-methoxymethamphetamine, PMMA) ............................1245 (e) Any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Etizolam..................................................................................2780 Some trade or other names:

(4-(2-chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine) (2) Mecloqualone..........................................................................2572 (3) Methaqualone..........................................................................2565 (4) Gamma hydroxybutyric acid...................................................2010 (5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name:

flualprazolam)....................................................2785 (6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f] [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name:

clonazolam)......................................2786 (7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f] [1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts of isomers (other name:

flubromazolam)..................................................2788 (8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e] [1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other HOUSE BILL No.

2365—page 11 name:

diclazepam)..................................................................2789 (f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

(1) Aminorex................................................................................1585 Some other names:

Aminoxaphen 2-amino-5-phenyl-2-oxazoline or 4,5-dihydro-5-phenyl-2-oxazolamine (2) Fenethylline.............................................................................1503 (3) N-ethylamphetamine...............................................................1475 (4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-phenyl- 2-oxazolamine)........................................................................1590 (5) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl- benzeneethanamine;

N,N-alpha-trimethylphenethylamine)...1480 (6) Cathinone (some other names:

2-amino-1-phenol-1-propanone, alpha-amino propiophenone, 2-amino propiophenone and norphedrone)...........................................................................1235 (7) Substituted cathinones Any compound, except bupropion or compounds listed under a different schedule, structurally derived from 2–aminopropan–1– one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:

(A) By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;

(B) by substitution at the 3-position with an acyclic alkyl substituent;

(C) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups;

or (D) by inclusion of the 2-amino nitrogen atom in a cyclic structure.

(8) N-benzylpiperazine (other names:

BZP, 1-benzylpiprazine)..7493 (9) Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine)........................1478 (10) 4,4′-Dimethylaminorex (4,4′-DMAR;

4,5-dihydro-4-methyl-5-(4- methylphenyl)-2-oxazolamine;

4-methyl-5-(4-methylphenyl)- 4,5-dihydro-1,3-oxazol-2-amine)............................................1595 (11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5- yl) amino]heptanoic acid).............................................................1219 (12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3- oxadiazol-3-ium-5-yl)carbamimidate)....................................1227 (13) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate).....1727 (g) Any material, compound, mixture or preparation that contains any quantity of the following substances:

(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of isomers (2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), its optical isomers, salts and salts of isomers (3) Tianeptine, its optical isomers, salts and salts of isomers (h) Any of the following cannabinoids, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Tetrahydrocannabinols............................................................7370 Meaning tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp.

and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as the following:

Delta 1 9 cis or HOUSE BILL No.

2365—page 12 trans tetrahydrocannabinol, and their optical isomers Delta 6 8 cis or trans tetrahydrocannabinol, and their optical isomers Delta 3,4 6a,10a cis or trans tetrahydrocannabinol, and its optical isomers (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.), except tetrahydrocannabinols in any of the following:

(A) Industrial hemp, as defined in K.S.A.

2-3901, and amendments thereto;

(B) solid waste, as defined in K.S.A.

65-3402, and amendments thereto, and hazardous waste, as defined in K.S.A.

65-3430, and amendments thereto, if such waste is the result of the cultivation, production or processing of industrial hemp, as defined in K.S.A.

2-3901, and amendments thereto, and such waste contains a delta-9 tetrahydrocannabinol concentration of not more than 0.3%;

or (C) hemp products, as defined in K.S.A.

2-3901, and amendments thereto, unless otherwise deemed unlawful pursuant to K.S.A.

2-3908, and amendments thereto.

For the purposes of this subsection, the dibenzopyran system is the numbering convention used to identify the carbon atoms of the chemical structure.

(2) Naphthylmethylindoles Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or not further substituted on the indole group to any extent and whether or not substituted on the benzyl or naphthyl ring to any extent.

(3) Naphthoylpyrroles Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2- (4-morpholinyl)ethyl group whether or not further substituted on the pyrrole group to any extent, whether or not substituted on the benzyl or naphthyl ring to any extent.

(4) Naphthylmethylindenes Any compound containing a naphthylmethylindene structure with substitution at the 3-position of the indene group by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2- (4-morpholinyl)ethyl group whether or not further substituted on the indene group to any extent, whether or not substituted on the benzyl or naphthyl ring to any extent.

(5) Cyclohexylphenols Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4- morpholinyl)ethyl group whether or not substituted on the cyclohexyl ring to any extent.

(6) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3- de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone.

Some trade or other names:

WIN 55,212-2.

(7) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol Some trade or other names:

HU-210, HU-211.

(8) Indole-3-carboxylate esters Any compound containing a 1H-indole-3-carboxylate ester structure with the ester oxygen bearing a naphthyl, quinolinyl, isoquinolinyl or adamantyl group and substitution at the 1 position of the indole ring by an alkyl, haloalkyl, cyanoalkyl, HOUSE BILL No.

2365—page 13 alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl- 2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl or benzyl groups to any extent.

(9) Indazole-3-carboxamides Any compound containing a 1H-indazole-3-carboxamide structure with substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1- amino-1-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and substitution at the 1 position of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2- (4-morpholinyl)ethyl group, whether or not further substituted on the indazole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1- oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups to any extent.

(10) Indole-3-carboxamides Any compound containing a 1H-indole-3-carboxamide structure with substitution at the nitrogen of the carboxamide by a naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1-amino- 1-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and substitution at the 1 position of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2- (4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not further substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups to any extent.

(11) (1H-indazol-3-yl)methanones Any compound containing a (1H-indazol-3-yl)methanone structure with the carbonyl carbon bearing a naphthyl group and substitution at the 1 position of the indazole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1- (N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indazole ring to any extent and whether or not substituted on the naphthyl or benzyl groups to any extent.

(12) (1H-indol-3-yl)methanones Any compound containing a (1H-indol-3-yl)methanone structure with the carbonyl carbon bearing a naphthyl, quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or tetramethylcyclopropyl group and substitution at the 1 position of the indole ring by an alkyl,haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2- piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl, phenyl, benzyl or tetramethylcyclopropyl groups to any extent.

(13) Hexahydrocannabinol (HHC) (14) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, its optical and geometric isomers, salts and salts of isomers (Some trade or ther names:

CUMYL–PEGACLONE;

SGT–151) ....7093 (i) (1) Unless specifically exempted or unless listed in schedules II through V of the uniform controlled substances act, any material, compound, mixture or preparation that contains any quantity of a fentanyl-related substance or that contains the salts, isomers and salts of isomers of a fentanyl-related substance whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.

HOUSE BILL No.

2365—page 14 (2) "Fentanyl-related substance" means any substance that is structurally related to fentanyl by one or more of the following modifications:

(A) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;

(B) substitution in or on the phenethyl group (or replacement as described in sub-paragraph (A)) with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;

(C) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;

(D) replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle;

or (E) replacement of the N-propionyl group by another acyl group.

202465-4109 Supp.is hereby amended to read as follows:

39-140165- is4109. hereby amended to read as follows:

39-1401.(a) The controlled substances listed in this section are included in schedule III and the number set forth opposite each drug or substance is the DEAcontrolled substances code which has been assigned to it.

As(b) Unless usedlisted in thisanother act:schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

(a) "Resident"(1) means:Any compound, mixture or preparation containing:

(1) Any(A) resident,Amobarbital............................................................................2126 as(B) definedSecobarbital.............................................................................2316 by(C) K.S.A.Pentobarbital...........................................................................2271 or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.

39-923,(2) andAny amendmentssuppository thereto;dosage form containing:

(A) Amobarbital............................................................................2126 (B) Secobarbital.............................................................................2316 (C) Pentobarbital...........................................................................2271 or (2) anyany individualsalt kept,of caredany for,of treated,these boardeddrugs orand otherwiseapproved accommodatedby inthe aFood medicaland careDrug facility;Administration for marketing only as a suppository.

or(3) (3) anyAny individual,substance kept,which caredcontains for,any treated,quantity boardedof a derivative of barbituric acid, or otherwiseany accommodatedsalt inof a statederivative psychiatricof hospitalbarbituric acid, except those substances which are specifically listed in other schedules.................................................................................2100 (4) Chlorhexadol...........................................................................2510 (5) Lysergic acid...........................................................................7300 (6) Lysergic acid amide.................................................................7310 (7) Methyprylon............................................................................2575 (8) Sulfondiethylmethane.............................................................2600 (9) Sulfonethylmethane................................................................2605 (10) Sulfonmethane........................................................................2610 (11) Tiletamine and zolazepam or stateany institutionsalt thereof.........................7295 Some trade or other names for peoplea withtiletamine-zolazepam intellectualcombination disability.product:

(b) "AdultTelazol careSome home"trade meansor theother samenames asfor definedtiletamine: in K.S.A.

39-923,2-(ethylamino)-2-(2- andthienyl)-cyclohexanone amendmentsSome thereto.trade or other names for zolazepam:

(c) "In4-(2-fluorophenyl)- need6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)- ofone, protectiveflupyrazapon services"(12) meansKetamine, thatits asalts, residentisomers, isand unablesalts toof performisomers...................7285 orSome obtainother servicesnames whichfor areketamine: necessary to maintain physical or mental health, or both.

HB(±)-2-(2-chlorophenyl)-2- 2365—Am.(methylamino)-cyclohexanone (13) Gamma hydroxybutyric acid, any salt, hydroxybutyric compound, derivative or preparation of gamma hydroxybutyric acid contained in a drug product for which an application has been approved under section 505 of the federal food, drug and cosmetic act (14) Embutramide...........................................................................2020 (15) Perampanel, its salts, isomers, and salts of isomers................2261 Some other names for perampanel:

by2-(2-oxo-1-phenyl-5-pyridin- SCHOUSE 8BILL (d) "ServicesNo. which are necessary to maintain physical and mental health" include, but are not limited to, the provision of medical care for physical and mental health needs, the relocation of a resident to a facility or institution able to offer such care, assistance in personal hygiene, food, clothing, adequately heated and ventilated shelter, protection from health and safety hazards, protection from maltreatment the result of which includes, but is not limited to, malnutrition, deprivation of necessities or physical punishment and transportation necessary to secure any of the above stated needs, except that this term shall not include taking such person into custody without consent, except as provided in this act.

(e) "Protective2365—page services"15 means2-yl-1,2 servicesdihydropyridin-3-yl) providedbenzonitrile by(c) Nalorphine................................................................................9400 the(d) Any statematerial, orcompound, othermixture governmentalor agencypreparation orcontaining any privateof organizationsthe following narcotic drugs or individualsany whichsalts arecalculated necessaryas tothe preventfree abuse,anhydrous neglectbase or exploitation.alkaloid, in limited quantities as set forth below:

Such(1) protectiveNot servicesmore shallthan include,1.8 butgrams of codeine or any of its salts per 100 milliliters or not bemore limitedthan to,90 evaluationmilligrams per dosage unit with an equal or greater quantity of thean needisoquinoline foralkaloid services,of assistanceopium .................................................................................................9803 (2) not more than 1.8 grams of codeine or any of its salts per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in obtainingrecognized appropriatetherapeutic socialamounts................................................................9804 services(3) andnot assistancemore than 1.8 grams of dihydrocodeine or any of its salts per milliliters or not more than 90 milligrams per dosage unit with one or more active, nonnarcotic ingredients in securingrecognized medicaltherapeutic andamounts................................................................9807 legal(4) services.not more than 300 milligrams of ethylmorphine or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts................................................................9808 (5) not more than 500 milligrams of opium per 100 milliliters or per grams or not more than 25 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts................................................................9809 (6) not more than 50 milligrams of morphine or any of its salts per milliliters or per grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts..............................................9810 (7) any material, compound, mixture or preparation containing any of the following narcotic drugs or their salts, as set forth below:

(f) "Abuse"(A) meansBuprenorphine.........................................................................9064 any(e) Unless actspecifically excepted or failureunless tolisted actin performedanother intentionallyschedule, orany recklesslymaterial, thatcompound, causesmixture or ispreparation likelywhich tocontains causeany harmquantity toof the following substances having a resident,stimulant including:effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Infliction(1) Those compounds, mixtures or preparations in dosage unit form containing any stimulant substance listed in schedule II, which compounds, mixtures or preparations were listed on August 25, 1971, as excepted compounds under section 308.32 of physicaltitle 21 of the code of federal regulations, and any other drug of the quantitive composition shown in that list for those drugs or mentalwhich injury;is the same, except that it contains a lesser quantity of controlled substances..............................................................1405 (2) Benzphetamine........................................................................1228 (3) Chlorphentermine....................................................................1645 (4) Chlortermine...........................................................................1647 (5) Phendimetrazine......................................................................1615 (f) Anabolic steroids.................................................................4000 "Anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:

(2) any(1) sexual3β,17-dihydroxy-5a-androstane act(2) with3α,17β-dihydroxy-5a-androstane a(3) resident5α-androstan-3,17-dione when(4) the1-androstenediol resident(3β,17β-dihydroxy-5α-androst-1-ene) does(5) not1-androstenediol consent(3α,17β-dihydroxy-5α-androst-1-ene) or(6) when4-androstenediol the(3β,17β-dihydroxy-androst-4-ene) other(7) person5-androstenediol knows(3β,17β-dihydroxy-androst-5-ene) or(8) should1-androstenedione know([5α]-androst-1-en-3,17-dione) thatHOUSE theBILL residentNo. is incapable of resisting or declining consent to the sexual act due to mental deficiency or disease or due to fear of retribution or hardship;

(3) unreasonable2365—page use16 of(9) a4-androstenedione physical(androst-4-en-3,17-dione) restraint,(10) isolation5-androstenedione or(androst-5-en-3,17-dione) medication(11) thatbolasterone harms(7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) or(12) isboldenone likely(17β-hydroxyandrost-1,4-diene-3-one) to(13) harmboldione a(androsta-1,4-diene-3,17-dione) resident;(14) calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) (15) clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) (16) dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α- methyl-androst-1,4-dien-3-one) (17) desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) (also known as "madol") (18) Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) (also known as "1-testosterone") (19) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one) (20) drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one) (21) ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) (22) fluoxymesterone (9-fluoro-17α-methyl-11β,17β- dihydroxyandrost-4-en-3-one) (23) formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost- 1,4-dien-3-one) (24) furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan) (25) 13β-ethyl-17β-hydroxygon-4-en-3-one (26) 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one) (27) 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one) (28) mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one) (29) mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one) (30) methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3- one) (31) methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene) (32) methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one) (33) methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one) (34) 17α-methyl-3β,17β-dihydroxy-5a-androstane (35) 17α-methyl-3α,17β-dihydroxy-5a-androstane (36) 17α-methyl-3β,17β-dihydroxyandrost-4-ene (37) 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β- hydroxyestr-4-en-3-one) (38) methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3- one) (39) methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3- one) (40) methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one) (41) mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one) (42) 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl- 5α-androst-1-en-3-one) (also known as "17-α-methyl-1- testosterone") (43) nandrolone (17β-hydroxyestr-4-en-3-one) (44) 19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene) (45) 19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene) (46) 19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene) (47) 19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene) (48) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17- dione) (49) 19-nor-4-androstenedione (estr-4-en-3,17-dione) (50) 19-nor-5-androstenedione (estr-5-en-3,17-dione) (51) norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one) (52) norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) (53) norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one) (54) normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one) (55) oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3- one) (56) oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one) (57) oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy- [5α]-androstan-3-one) (58) prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole) HOUSE BILL No.

(4) unreasonable2365—page use17 of(59) astanozolol physical(17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]- orpyrazole) chemical(60) restraint,stenbolone medication(17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one) or(61) isolationtestolactone as(13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17- punishment,oic foracid convenience,lactone) in(62) conflicttestosterone with(17β-hydroxyandrost-4-en-3-one) a(63) physician'stetrahydrogestrinone orders(13β, or17α-diethyl-17β-hydroxygon-4,9,11- astrien-3-one) a(64) substitutetrenbolone for(17β-hydroxyestr-4,9,11-trien-3-one) treatment,(65) except5α-androstan-3,6,17-trione; where such conduct or physical restraint is in furtherance of the health and safety of the resident or another resident;

(5) a(66) threat6-bromo-androsta-1,4-diene-3,17-dione; or menacing conduct directed toward a resident that results or might reasonably be expected to result in fear or emotional or mental distress to a resident;

(6) fiduciary(67) abuse;6-bromo-androstan-3,17-dione;

or(68) (7) omission4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol; or deprivation by a caretaker or another person of goods or services which are necessary to avoid physical or mental harm or illness.

(g) "Neglect"(69) means4-chloro-17α-methyl-androst-4-ene-3β,17β-diol; the failure or omission by one's self, caretaker or another person with a duty to provide goods or services which are reasonably necessary to ensure safety and well-being and to avoid physical or mental harm or illness.

(h) "Caretaker"(70) means4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one; a person or institution who has assumed the responsibility, whether legally or not, for the care of the resident HB 2365—Am.

by(71) SC4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione; 9 voluntarily, by contract or by order of a court of competent jurisdiction.

(i) "Exploitation"(72) means2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one; misappropriation of resident property or intentionally taking unfair advantage of an adult's physical or financial resources for another individual's personal or financial advantage by the use of undue influence, coercion, harassment, duress, deception, false representation or false pretense by a caretaker or another person.

(j) "Medical(73) care2α,3α-epithio-17α-methyl-5α-androstan-17β-ol; facility" means a facility licensed under K.S.A.

65-(74) 425estra-4,9,11-triene-3,17-dione; et seq., and amendments thereto, but shall not include, for purposes of this act, a state psychiatric hospital or state institution for people with intellectual disability, including Larned state hospital, Osawatomie state hospital and Rainbow mental health facility, Kansas neurological institute and, Parsons state hospital and training center south central regional mental health hospital.

(k) "Fiduciary(75) abuse"[3,2-c]furazan-5α-androstan-17β-ol; means a situation in which any person who is the caretaker of, or who stands in a position of trust to, a resident, takes, secretes, or appropriates the resident's money or property, to any use or purpose not in the due and lawful execution of such person's trust.

(l) "State(76) psychiatric18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one; hospital" means Larned state hospital, Osawatomie state hospital and Rainbow mental health facility south central regional mental health hospital.

(m) "State(77) institution4-hydroxy-androst-4-ene-3,17-dione; for people with intellectual disability" means Kansas neurological institute and Parsons state hospital and training center.

(n) "Report"(78) means17β-hydroxy-androstano[2,3-d]isoxazole; a description or accounting of an incident or incidents of abuse, neglect or exploitation under this act and for the purposes of this act shall not include any written assessment or findings.

(o) "Law(79) enforcement"17β-hydroxy-androstano[3,2-c]isoxazole; means the public office which is vested by law with the duty to maintain public order, make arrests for crimes and investigate criminal acts, whether that duty extends to all crimes or is limited to specific crimes.

(p) "Legal(80) representative"3β-hydroxy-estra-4,9,11-triene-17-one; means an agent designated in a durable power of attorney, power of attorney or durable power of attorney for health care decisions or a court appointed guardian, conservator or trustee.

(q) "Financial(81) institution"17α-methyl-androsta-1,4-diene-3,17β-diol; means any bank, trust company, escrow company, finance company, saving institution, credit union or fiduciary financial institution, chartered and supervised under state or federal law.

(r) "Governmental(82) assistance17α-methyl-5α-androstan-17β-ol; provider" means an agency, or employee of such agency, which is funded solely or in part to provide assistance within the Kansas senior care act, K.S.A.

75-5926(83) et17α-methyl-androstan-3-hydroxyimine-17β-ol; seq., and amendments thereto, including medicaid and medicare.

No(84) person6α-methyl-androst-4-ene-3,17-dione; shall be considered to be abused, neglected or exploited or in need of protective services for the sole reason that such person relies upon spiritual means through prayer alone for treatment in accordance HB 2365—Am.

by(85) SC17α-methyl-androst-2-ene-3,17β-diol; 10 with the tenets and practices of a recognized church or religious denomination in lieu of medical treatment.

(86) [3,2-c]pyrazole-androst-4-en-17β-ol;

(87) any salt, ester, or isomer of a drug or substance described or listed in this paragraph, if that salt, ester, or isomer promotes muscle growth.

(A) Except as provided in (B), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States' secretary of health and human services for such administration.

(B) If any person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection (f).

(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States food and drug administration approved product.....................................................................7369 Some other names for dronabinol:

(6aR-trans)-6a,7,8,10a- tetrahydro-6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l, or (-)-delta-9-(trans)-tetrahydrocannabinol.

(h) The board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.

39-16022025 isSupp. hereby amended to read as follows:

39-65-4111 1602.is hereby amended to read as HOUSE BILL No.

As2365—page used18 infollows: K.S.A.

39-160165-4111. through 39-1612, and amendments thereto:

(a) "Targeted(a) population"The meanscontrolled thesubstances populationlisted group designated by rules and regulations of the secretary as most in needthis ofsection mental health services that are funded,included in wholeschedule orIV in part, by state or other public funding sources, and suchthe groupnumber shallset includeforth adultsopposite witheach severedrug andor persistentsubstance mentalis illness,the severelyDEA emotionallycontrolled disturbedsubstances childrencode andthat adolescentshas andbeen otherassigned individualsto atit. risk of requiring institutional care.

(b) "Community(b) Any basedmaterial, mentalcompound, healthmixture services"or includes,preparation butthat iscontains notany limitedquantity to,of evaluationthe andfollowing diagnosis,substances caseincluding managementits services,salts, mentalisomers health inpatient and outpatientsalts services, prescription and management of psychotropicisomers medication,whenever prevention,the education,existence consultation,of treatmentsuch andsalts, rehabilitationisomers services, 24-hour emergency services, and anysalts facilitiesof requiredisomers therefor,is thatpossible are provided within onethe orspecific morechemical localdesignation communitiesand inhaving order to provide a continuumpotential offor careabuse andassociated supportwith servicesa todepressant enableeffect mentallyon ill persons, including targeted population members, to function outside of inpatient institutions to the extentcentral ofnervous theirsystem: capabilities.

Community(1) basedAlprazolam.........................................................................2882 mental(2) healthBarbital...............................................................................2145 services(3) alsoBrexanolone........................................................................2400 include(4) assistanceBromazepam in......................................................................2748 securing(5) employmentCamazepam........................................................................2749 services,(6) housingCarisoprodol.......................................................................8192 services,(7) medicalChloral andbetaine...................................................................2460 dental(8) careChloral andhydrate...................................................................2465 other(9) supportChlordiazepoxide................................................................2744 services.(10) Clobazam............................................................................2751 (11) Clonazepam........................................................................2737 (12) Clorazepate.........................................................................2768 (13) Clotiazepam........................................................................2752 (14) Cloxazolam.........................................................................2753 (15) Daridorexant.......................................................................2410 (16) Delorazepam.......................................................................2754 (17) Diazepam............................................................................2765 (18) Dichloralphenazone............................................................2467 (19) Estazolam...........................................................................2756 (20) Ethchlorvynol.....................................................................2540 (21) Ethinamate..........................................................................2545 (22) Ethyl loflazepate.................................................................2758 (23) Fludiazepam.......................................................................2759 (24) Flunitrazepam.....................................................................2763 (25) Flurazepam.........................................................................2767 (26) Fospropofol........................................................................2138 (27) Halazepam..........................................................................2762 (28) Haloxazolam.......................................................................2771 (29) Ketazolam...........................................................................2772 (30) Lemborexant.......................................................................2245 (31) Loprazolam.........................................................................2773 (32) Lorazepam..........................................................................2885 (33) Lormetazepam....................................................................2774 (34) Mebutamate........................................................................2800 (35) Medazepam........................................................................2836 (36) Meprobamate......................................................................2820 (37) Methohexital.......................................................................2264 (38) Methylphenobarbital (mephobarbital)................................2250 (39) Midazolam..........................................................................2884 (40) Nimetazepam......................................................................2837 (41) Nitrazepam.........................................................................2834 (42) Nordiazepam......................................................................2838 (43) Oxazepam...........................................................................2835 (44) Oxazolam............................................................................2839 (45) Paraldehyde........................................................................2585 (46) Petrichloral.........................................................................2591 (47) Phenobarbital......................................................................2285 (48) Pinazepam..........................................................................2883 (49) Prazepam............................................................................2764 (50) Quazepam...........................................................................2881 (51) Remimazolam.....................................................................2846 (52) Temazepam.........................................................................2925 (53) Tetrazepam.........................................................................2886 (54) Triazolam............................................................................2887 HOUSE BILL No.

(c) "Mental2365—page health19 center"(55) meansZolpidem............................................................................2783 (56) Zaleplon..............................................................................2781 (57) Zopiclone............................................................................2784 (58) Alfaxalone..........................................................................2731 (59) Suvorexant..........................................................................2223 (60) Zuranolone.........................................................................2420 (c) Any material, compound, mixture or preparation that contains any communityquantity mentalof healthlorcaserin center(1625), asincluding definedits insalts, K.S.A.isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C.

39-2002,§ and812; amendments thereto.

(d) "Secretary"21 meansC.F.R. the secretary for aging and disability services.

(e) "Department"§ means1308.14). the Kansas department for aging and disability services.

(f) "State(d) Unless psychiatricspecifically hospital"excepted meansor Osawatomieunless statelisted hospital,in Rainbowanother mentalschedule, healthany facilitymaterial, compound, mixture or Larnedpreparation statethat hospitalcontains orany southquantity of the following substances having a stimulant effect on the central regionalnervous mentalsystem, healthincluding hospital.its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(g) "Mental(1) healthCathine reform((+)-norpseudoephedrine).....................................1230 phased(2) program"Diethylpropion....................................................................1610 means(3) theFencamfamin......................................................................1760 program(4) inFenproporex........................................................................1575 three(5) phasesMazindol.............................................................................1605 for(6) Mefenorex..........................................................................1580 (7) Pemoline (including organometallic complexes and chelates thereof)...............................................................................1530 (8) Phentermine........................................................................1640 The provisions of subsection (d)(8) shall expire on the implementationdate phentermine and its salts and isomers are removed from schedule IV of mentalthe healthfederal reformcontrolled insubstances Kansasact as(21 follows:U.S.C.

(1) The§ first812; phase covers the counties in the Osawatomie state hospital catchment area and is to commence on July 1, 1990, and is to be completed by June 30, 1994;

(2) the21 secondC.F.R. phase covers the counties in the Topeka state hospital catchment area and is to commence on July 1, 1992, and is to be completed by June 30, 1996;

and§ (3) the1308.14). third phase covers the counties in the Larned state hospital catchment area and is to commence on July 1, 1993, and is to be completed by June 30, 1997.

HB(9) 2365—Am.Pipradrol.............................................................................1750 (10) Serdexmethylphenidate......................................................1729 (11) SPA((-)-1-dimethylamino-1, 2-diphenylethane)................1635 (12) Sibutramine........................................................................1675 (13) Solriamfetol (2-amino-3-phenylpropyl carbamate;

bybenzenepropanol, SCbeta-amino-, 11carbamate (h) "Screening"(ester))............1650 means(14) theMondafinilModafinil..........................................................1680 process(e) Unless performedspecifically byexcepted aor participatingunless communitylisted mentalin healthanother center,schedule, pursuantany tomaterial, acompound, contractmixture enteredor intopreparation withthat contains any quantity of the secretaryfollowing, underincluding K.S.A.salts thereof:

39-1610,(1) andPentazocine.........................................................................9709 amendments(2) thereto,Butorphanol to(including determineits whetheroptical aisomers).......................9720 person,(3) underEluxadoline either(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6- voluntarydimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol- or2-yl)ethyl]amino]methyl]-2-methoxybenzoic involuntaryacid) procedures,(including canits beoptical evaluatedisomers) orand treated,its orsalts, canisomers, beand bothsalts evaluatedof andisomers..........................................................................9725 treated,(f) Unless specifically excepted or unless listed in theanother communityschedule, any material, compound, mixture or shouldpreparation becontaining referredany toof the appropriatefollowing statenarcotic psychiatricdrugs, hospitalor fortheir suchsalts treatmentcalculated oras evaluationthe free anhydrous base or foralkaloid, bothin treatmentlimited andquantities evaluation.as set forth below:

(i) "Osawatomie(1) stateNot hospitalmore catchmentthan area"1 means,milligram exceptof asdifenoxin otherwiseand definednot byless rulesthan 25 micrograms of atropine sulfate per dosage unit.................9167 (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2- diphenyl-3-methyl-2-propion-oxybutane)..........................9278 (3) 2-[(dimethylamino)methyl]-1-(3- methoxyphenyl)cyclohexanol, its salts, optical and regulationsgeometric isomers and salts of thethese secretaryisomers adopted(including pursuanttramadol)....9752 to(g) Butyl K.S.A.nitrite and its salts, isomers, esters, ethers or their salts.

39-1613,(h) The board may except by rule and amendmentsregulation thereto,any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the areaapplication composedof all or any part of this act if the followingcompound, counties:mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central HOUSE BILL No.

Allen,2365—page Anderson,20 Atchison,nervous Bourbon,system, Brown,and Butler,if Chase,the Chautauqua,admixtures Cherokee,are Clay,included Cloud,therein Coffey,in Cowley,combinations, Crawford,quantity, Doniphan,proportion Douglas,or Elk,concentration Franklin,that Geary,vitiate Greenwood,the Jackson,potential Jefferson,for Jewell,abuse Johnson,of Labette,the Leavenworth,substances Linn,that Lyon,have Marshall,a Miami,depressant Mitchell,effect Montgomery,on Morris,the Nemaha,central Neosho,nervous Osage,system. Pottawatomie, Republic, Riley, Sedgwick, Shawnee, Wabaunsee, Washington, Wilson, Woodson and Wyandotte.

(j) "Larned state hospital catchment area" means, except as otherwise defined by rules and regulations of the secretary adopted pursuant to K.S.A.

39-1613, and amendments thereto, the area composed of the following counties:

Barber, Barton, Cheyenne, Clark, Comanche, Decatur, Dickinson, Edwards, Ellis, Ellsworth, Finney, Ford, Gove, Graham, Grant, Gray, Greeley, Hamilton, Harper, Harvey, Haskell, Hodgeman, Kearny, Kingman, Kiowa, Lane, Lincoln, Logan, Marion, McPherson, Meade, Morton, Ness, Norton, Osborne, Ottawa, Pawnee, Phillips, Pratt, Rawlins, Reno, Rice, Rooks, Rush, Russell, Saline, Scott, Seward, Sheridan, Sherman, Smith, Stafford, Stanton, Stevens, Sumner, Thomas, Trego, Wallace and Wichita.

(k) "Catchment area" means the Osawatomie state hospital catchment area or the Larned state hospital catchment area or the south central regional mental health hospital catchment area as defined in subsections (i) and (m).

(l) "Participating mental health center" means a mental health center that has entered into a contract with the secretary for aging and disability services to provide screening, treatment and evaluation, court ordered evaluation and other treatment services pursuant to the care and treatment act for mentally ill persons, in keeping with the phased concept of the mental health reform act.

(m) "South central regional mental hospital catchment area" means, except as otherwise defined by rules and regulations of the secretary adopted pursuant to K.S.A.

39-1613, and amendments thereto, the area composed of the following counties:

Sedgwick, Butler, Cowley, Harvey and HB 2365—Am.

by SC 12 Sumner.

5. K.S.A.5 K.S.A.

39-161365-4109 isand herebyK.S.A amended2025 toSupp. read as follows:

39-21-5701, 1613.65-4105 and 65-4111 are hereby repealed.

(a) The secretary for aging and disability services is hereby authorized to adopt rules and regulations to define and redefine the Osawatomie state hospital catchment area and Larned state hospital catchment area areas as may be necessary in the opinion of the secretary for aging and disability services to accommodate shifts in populations in need of mental health services within available community mental health facility and state institution hospital capacities and resources and in accordance with the following:(1) Each such catchment area shall be defined by contiguous counties that are designated by name;

(2) no county shall be included in more than one such catchment area;

(3) each county shall be included in the Osawatomie state hospital catchment area or Larned state hospital catchment area;

and (4) No designated community mental health center shall be included in more than one such catchment area.

The designation of a county to a particular catchment area shall not prevent the admission of persons to a state hospital in another catchment area when there are insufficient capacities and resources currently available in the designated state hospital catchment area.

(b) Each rule and regulation adopted, amended or revived under this section shall be published in its entirety in the Kansas register in the first issue published after such adoption, amendment or revival.

6. K.S.A.6. This act shall take effect and be in force from and after its publication in the statute book.

40-3401I is hereby amendedcertify tothat readthe asabove follows:B ILL originated in the HOUSE , and was adopted by that body H OUSE adopted Conference Committee Report Speaker of the House.

40-Chief 3401.Clerk of the House.

AsPassed usedthe inSENATE thisas act:amended SENATE adopted Conference Committee Report President of the Senate.

(a) "Applicant"Secretary meansof anythe healthcareSenate. provider.

(b) "BasicA coverage"PPROVED meansGovernor. a policy of professional liability insurance required to be maintained by each healthcare provider pursuant to the provisions of K.S.A.

40-3402(a) or (b), and amendments thereto.

(c) "Commissioner" means the commissioner of insurance.

(d) "Fiscal year" means the year commencing on the effective date of this act and each year, commencing on the first day of July thereafter.

(e) "Fund" means the healthcare stabilization fund established pursuant to K.S.A.

40-3403(a), and amendments thereto.

(f) (1) "Healthcare provider" means a:

(A) Person licensed to practice any branch of the healing arts by the state board of healing arts, a;

(B) person who holds a temporary permit to practice any branch of the healing arts issued by the state board of healing arts, a;

(C) person engaged in a postgraduate training program approved by the state board of healing arts, a;

(D) medical care facility licensed by the state of Kansas, a;

(E) podiatrist licensed by the state board of healing arts, a;

HB 2365—Am.

by SC 13 (F) health maintenance organization issued a certificate of authority by the commissioner, an;

(G) optometrist licensed by the board of examiners in optometry, a;

(H) pharmacist licensed by the state board of pharmacy, a;

(I) licensed professional nurse who is authorized to practice as a registered nurse anesthetist, a;

(J) licensed professional nurse who has been granted a temporary authorization to practice nurse anesthesia under K.S.A.

65-1153, and amendments thereto, a;

(K) professional corporation organized pursuant to the professional corporation law of Kansas by persons who are authorized by such law to form such a corporation and who are healthcare providers as defined by this subsection, a;

(L) Kansas limited liability company organized for the purpose of rendering professional services by its members who are healthcare providers as defined by this subsection and who are legally authorized to render the professional services for which the limited liability company is organized, a;

(M) partnership of persons who are healthcare providers under this subsection, a;

(N) Kansas not-for-profit corporation organized for the purpose of rendering professional services by persons who are healthcare providers as defined by this subsection, a;

(O) nonprofit corporation organized to administer the graduate medical education programs of community hospitals or medical care facilities affiliated with the university of Kansas school of medicine, a;

(P) dentist certified by the state board of healing arts to administer anesthetics under K.S.A.

65-2899, and amendments thereto, a;

(Q) psychiatric hospital licensed prior to January 1, 1988, and continuously thereafter under K.S.A.

2015 Supp.

75-3307b, prior to its repeal, and K.S.A.

39-2001 et seq., and amendments thereto, or a mental health center or mental health clinic licensed by the state of Kansas.

On and after January 1, 2015, "healthcare provider" also means a;

(R) physician assistant licensed by the state board of healing arts, a;

(S) licensed advanced practice registered nurse who is authorized by the board of nursing to practice as an advanced practice registered nurse in the classification of a nurse-midwife, a;

(T) licensed advanced practice registered nurse who has been granted a temporary authorization by the board of nursing to practice as an advanced practice registered nurse in the classification of a nurse-midwife, a;

(U) nursing facility licensed by the state of Kansas, an;

(V) assisted living facility licensed by the state of Kansas;

or HB 2365—Am.

by SC 14 (W) a residential healthcare facility licensed by the state of Kansas.

(2) "Healthcare provider" does not include:

(1)(A) Any state institution for people with intellectual disability;

(2)(B) any state psychiatric hospital;

(3)(C) any person holding an exempt license issued by the state board of healing arts or the board of nursing;

(4)(D) any person holding a visiting clinical professor license from the state board of healing arts;

(5)(E) any person holding an inactive license issued by the state board of healing arts;

(6)(F) any person holding a federally active license issued by the state board of healing arts;

(7)(G) an advanced practice registered nurse who is authorized by the board of nursing to practice as an advanced practice registered nurse in the classification of nurse-midwife or nurse anesthetist and who practices solely in the course of employment or active duty in the United States government or any of its departments, bureaus or agencies or who provides professional services as a charitable healthcare provider as defined under K.S.A.

75-6102, and amendments thereto;

or (8)(H) a physician assistant licensed by the state board of healing arts who practices solely in the course of employment or active duty in the United States government or any of its departments, bureaus or agencies or who provides professional services as a charitable healthcare provider as defined under K.S.A.

75-6102, and amendments thereto.

(g) "Inactive healthcare provider" means a person or other entity who purchased basic coverage or qualified as a self-insurer on or subsequent to the effective date of this act but who, at the time a claim is made for personal injury or death arising out of the rendering of or the failure to render professional services by such healthcare provider, does not have basic coverage or self-insurance in effect solely because such person is no longer engaged in rendering professional service as a healthcare provider.

(h) "Insurer" means any corporation, association,reciprocal exchange, inter-insurer and any other legal entity authorized to write bodily injury or property damage liability insurance in this state, including workers compensation and automobile liability insurance, pursuant to the provisions of the acts contained in article 9, 11, 12 or 16 of chapter 40 of the Kansas StatutesAnnotated, and amendments thereto.

(i) "Plan" means the operating and administrative rules and procedures developed by insurers and rating organizations or the commissioner to make professional liability insurance available to healthcare providers.

(j) "Professional liability insurance" means insurance providing coverage for legal liability arising out of the performance of professional HB 2365—Am.

by SC 15 services rendered or that should have been rendered by a healthcare provider.

(k) "Rating organization" means a corporation, an unincorporated association, a partnership or an individual licensed pursuant to K.S.A.

40- 956, and amendments thereto, to make rates for professional liability insurance.

(l) "Self-insurer" means a healthcare provider who qualifies as a self- insurer pursuant to K.S.A.

40-3414, and amendments thereto.

(m) "Medical care facility" means the same when used in the healthcare provider insurance availability act as defined in K.S.A.

65-425, and amendments thereto, except that as used in the healthcare provider insurance availability act such term, as it relates to insurance coverage under the healthcare provider insurance availability act, also includes any director, trustee, officer or administrator of a medical care facility.

(n) "Mental health center" means a mental health center licensed by the state of Kansas under K.S.A.

39-2001 et seq., and amendments thereto, except that as used in the healthcare provider insurance availability act such term, as it relates to insurance coverage under the healthcare provider insurance availability act, also includes any director, trustee, officer or administrator of a mental health center.

(o) "Mental health clinic" means a mental health clinic licensed by the state of Kansas under K.S.A.

39-2001 et seq., and amendments thereto, except that, as used in the healthcare provider insurance availability act, such term, as it relates to insurance coverage under the healthcare provider insurance availability act, also includes any director, trustee, officer or administrator of a mental health clinic.

(p) "State institution for people with intellectual disability" means Winfield state hospital and training center, Parsons state hospital and training center and the Kansas neurological institute.

(q) "State psychiatric hospital" means Larned state hospital, Osawatomie state hospital and Rainbow mental health facility south central regional mental health hospital.

(r) "Person engaged in residency training" means:

(1) A person engaged in a postgraduate training program approved by the state board of healing arts who is employed by and is studying at the university of Kansas medical center only when such person is engaged in medical activities that do not include extracurricular, extra-institutional medical service for which such person receives extra compensation and that have not been approved by the dean of the school of medicine and the executive vice-chancellor of the university of Kansas medical center.

Persons engaged in residency training shall be considered resident healthcare providers for purposes of K.S.A.

40-3401 et seq., and amendments thereto;

and HB 2365—Am.

by SC 16 (2) a person engaged in a postgraduate training program approved by the state board of healing arts who is employed by a nonprofit corporation organized to administer the graduate medical education programs of community hospitals or medical care facilities affiliated with the university of Kansas school of medicine or who is employed by an affiliate of the university of Kansas school of medicine as defined in K.S.A.

76-367, and amendments thereto, only when such person is engaged in medical activities that do not include extracurricular, extra-institutional medical service for which such person receives extra compensation and that have not been approved by the chief operating officer of the nonprofit corporation or the chief operating officer of the affiliate and the executive vice-chancellor of the university of Kansas medical center.

(s) "Full-time physician faculty employed by the university of Kansas medical center" means a person licensed to practice medicine and surgery who holds a full-time appointment at the university of Kansas medical center when such person is providing healthcare.

A person licensed to practice medicine and surgery who holds a full-time appointment at the university of Kansas medical center may also be employed part-time by the United States department of veterans affairs if such employment is approved by the executive vice-chancellor of the university of Kansas medical center.

(t) "Sexual act" or "sexual activity" means that sexual conduct that constitutes a criminal or tortious act under the laws of the state of Kansas.

(u) "Board" means the board of governors created by K.S.A.

40-3403, and amendments thereto.

(v) "Board of directors" means the governing board created by K.S.A.

40-3413, and amendments thereto.

(w) "Locum tenens contract" means a temporary agreement not exceeding 182 days per calendar year that employs a healthcare provider to actively render professional services in this state.

(x) "Professional services" means patient care or other services authorized under the act governing licensure of a healthcare provider.

(y) "Healthcare facility" means a nursing facility, an assisted living facility or a residential healthcare facility as all such terms are defined in K.S.A.

39-923, and amendments thereto.

(z) "Charitable healthcare provider" means the same as defined in K.S.A.

75-6102, and amendments thereto.

Sec.

7. K.S.A.

41-1126 is hereby amended to read as follows:

41- 1126.

(a) In addition to other purposes for which expenditures may be made from the other state fees fund of the Kansas department for aging and disability services, moneys in the other state fees fund of the Kansas department for aging and disability services shall be used by the secretary for aging and disability services to provide financial assistance to HB 2365—Am.

by SC 17 community-based alcoholism and intoxication treatment programs for the following purposes:

(1) Matching money under title XX of the federal social security act to purchase treatment services from approved treatment facilities;

(2) providing start-up or expansion grants for halfway houses or rehabilitation centers for alcoholics;

(3) purchasing services from approved treatment facilities for persons who are needy but who are not eligible for assistance under either title XIX or title XX of the federal social security act, and administrative costs of the alcohol and drug abuse section which shall not exceed 10% of the total moneys in the community alcoholism and intoxication programs fund;

and (4) assisting to develop programs for prevention, education, early identification and facility assistance and review team.

(b) No state alcohol treatment program at Osawatomie state hospital, Rainbow mental health facility or Larned state hospital or south central regional mental health hospital shall receive any moneys under the provisions of subsection (a) of this section.

(c) There is hereby established in the state treasury the community alcoholism and intoxicatthn programs fund.

(d) On or before the 10 day of each month, the director of accounts and reports shall transfer from the state general fund to the community alcoholism and intoxication programs fund interest earnings based on:

(1) The average daily balance of moneys in the community alcoholism and intoxication programs fund for the preceding month;